Invention Grant
- Patent Title: Heterocyclic inhibitors of glutaminase
-
Application No.: US15700796Application Date: 2017-09-11
-
Publication No.: US09938267B2Publication Date: 2018-04-10
- Inventor: Jim Li , Lijing Chen , Bindu Goyal , Guy Laidig , Timothy F. Stanton , Eric B. Sjogren
- Applicant: Calithera Biosciences, Inc.
- Applicant Address: US CA South San Francisco
- Assignee: Calithera Biosciences, Inc.
- Current Assignee: Calithera Biosciences, Inc.
- Current Assignee Address: US CA South San Francisco
- Agency: Foley Hoag LLP
- Agent David P. Halstead
- Main IPC: C07D417/14
- IPC: C07D417/14 ; C07D285/135 ; C07D285/125 ; A61N7/00 ; A61N5/10 ; A61N5/00 ; A61K45/06 ; A61K31/5377 ; A61K31/506 ; A61K31/501 ; A61K31/433 ; C07D417/06 ; A61B18/02
Abstract:
The invention relates to novel heterocyclic compounds and pharmaceutical preparations thereof. The invention further relates to methods of treatment using the novel heterocyclic compounds of the invention.
Public/Granted literature
- US20170369485A1 HETEROCYCLIC INHIBITORS OF GLUTAMINASE Public/Granted day:2017-12-28
Information query
